Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fluconazole donation and outcomes assessment in cryptococcal meningitis.

× No keyword cloud information.

8 in total

1. Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002-2003 and 2007-2008.

Authors: Nelesh P Govender; Jaymati Patel; Marelize van Wyk; Tom M Chiller; Shawn R Lockhart
Journal: Antimicrob Agents Chemother Date: 2011-03-28 Impact factor: 5.191

Review 2. Asymptomatic cryptococcemia in resource-limited settings.

Authors: Ana-Claire Meyer; Mark Jacobson
Journal: Curr HIV/AIDS Rep Date: 2013-09 Impact factor: 5.071

3. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy.

Authors: Andrew Kambugu; David B Meya; Joshua Rhein; Meagan O'Brien; Edward N Janoff; Allan R Ronald; Moses R Kamya; Harriet Mayanja-Kizza; Merle A Sande; Paul R Bohjanen; David R Boulware
Journal: Clin Infect Dis Date: 2008-06-01 Impact factor: 9.079

4. The impact of routine cryptococcal antigen screening on survival among HIV-infected individuals with advanced immunosuppression in Kenya.

Authors: A-C L Meyer; C K Kendi; J A Penner; N Odhiambo; B Otieno; E Omondi; E Opiyo; E A Bukusi; C R Cohen
Journal: Trop Med Int Health Date: 2013-02-01 Impact factor: 2.622

5. Symptomatic relapse of HIV-associated cryptococcal meningitis in South Africa: the role of inadequate secondary prophylaxis.

Authors: Joseph N Jarvis; Graeme Meintjes; Zomzi Williams; Kevin Rebe; Thomas S Harrison
Journal: S Afr Med J Date: 2010-06

Fluconazole donation and outcomes assessment in cryptococcal meningitis.

1. Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002-2003 and 2007-2008.

Review 2. Asymptomatic cryptococcemia in resource-limited settings.

3. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy.

4. The impact of routine cryptococcal antigen screening on survival among HIV-infected individuals with advanced immunosuppression in Kenya.

5. Symptomatic relapse of HIV-associated cryptococcal meningitis in South Africa: the role of inadequate secondary prophylaxis.

6. Neuromeningeal cryptococcosis in sub-Saharan Africa: Killer disease with sparse data.

Review 7. Cryptococcal meningitis: epidemiology and therapeutic options.

Review 8. Treatment of cryptococcal meningitis in resource limited settings.